• Provides mechanical support to healing tissues while eluting an anti-inflammatory steroid, mometasone furoate (MF).
• Designed for simple in-office delivery and removal
• Designed to exhibit optimal kinetics: releases drug at a known and predictable rate over time
• Corticosteroids are known to alleviate inflammation, diminish scarring and adhesions, if bioavailable for days rather than hours
• Addresses a +$750MM annual US market opportunity

The Restora drug-eluting spacer is currently under development and not commercially available